Opinion
Cancer care in the US -- looking back, looking forward
Begin thinking of your business as a 'disease' company vs. a 'drug' company
Industry collaborates on logistics and supply chain security
With Rx-360 already at critical mass and delivering results, the call is out for more participation . . .
Recognizing Critical Gaps in Today's Supply Chain for Temperature-Sensitive Drugs
Regulation, communications and accountability are the sources of current problems
The potential of translational research for new medicines
The proposed federal National Center for Advancing Translational Sciences holds promise for drug development . . .
The Battle for Control of Specialty Drugs
Specialty distributors, specialty pharmacies and healthcare providers are all competing for a dominant position in drug delivery and reimbursement . . .
ACOs and Their Impact on Pharma
Accountable care organizations will seek 'economic and clinical value' for pharmaceuticals . . .
Fix the Drug Shortage Problem- Now
As being reported in this issue and the recent past, the number of drugs in short supply has been growing, and now tops 210. This growth has occurred despite the efforts of the FDA Drug Shortage Program, which has averted dozens of shortages . . .
Progress on Pharmaceutical Cargo Security
Industry is succeeding in reducing transportation risks, but the job is not finished . . .
Drug shortages are opening the door to price gouging
Hospital pharmacies need to be vigilant in ensuring safe supplies of scarce drugs . . .
Bloodied But Unbowed on the Personalized Medicine Battlefront
Do Dendreon's troubles with over-optimistic sales forecasts put a cap on the promise of personalized medicine?
 
Previous   1   2   3
 
 
 
  
 
  
   
   
  |     |     |     |     |     |     |     |  
©2013 Pharmaceutical Commerce. All Rights Reserved.  |  Website managed and designed by OffWhite.